GCTK vs. LFWD, BTCY, ICU, PAVM, CODX, ALUR, PSTV, SSKN, MHUA, and POAI
Should you be buying GlucoTrack stock or one of its competitors? The main competitors of GlucoTrack include ReWalk Robotics (LFWD), Biotricity (BTCY), SeaStar Medical (ICU), PAVmed (PAVM), Co-Diagnostics (CODX), Allurion Technologies (ALUR), Plus Therapeutics (PSTV), STRATA Skin Sciences (SSKN), Meihua International Medical Technologies (MHUA), and Predictive Oncology (POAI). These companies are all part of the "medical equipment" industry.
GlucoTrack vs.
ReWalk Robotics (NASDAQ:LFWD) and GlucoTrack (NASDAQ:GCTK) are both small-cap computer and technology companies, but which is the better business? We will compare the two companies based on the strength of their media sentiment, valuation, dividends, community ranking, institutional ownership, analyst recommendations, risk, earnings and profitability.
GlucoTrack has a net margin of 0.00% compared to ReWalk Robotics' net margin of -77.21%. ReWalk Robotics' return on equity of -43.02% beat GlucoTrack's return on equity.
ReWalk Robotics currently has a consensus target price of $9.00, suggesting a potential upside of 656.30%. Given ReWalk Robotics' stronger consensus rating and higher probable upside, research analysts clearly believe ReWalk Robotics is more favorable than GlucoTrack.
ReWalk Robotics has a beta of 0.25, meaning that its stock price is 75% less volatile than the S&P 500. Comparatively, GlucoTrack has a beta of -0.14, meaning that its stock price is 114% less volatile than the S&P 500.
In the previous week, ReWalk Robotics had 6 more articles in the media than GlucoTrack. MarketBeat recorded 8 mentions for ReWalk Robotics and 2 mentions for GlucoTrack. GlucoTrack's average media sentiment score of 0.22 beat ReWalk Robotics' score of -0.23 indicating that GlucoTrack is being referred to more favorably in the news media.
ReWalk Robotics received 11 more outperform votes than GlucoTrack when rated by MarketBeat users.
26.8% of ReWalk Robotics shares are owned by institutional investors. Comparatively, 10.9% of GlucoTrack shares are owned by institutional investors. 2.5% of ReWalk Robotics shares are owned by company insiders. Comparatively, 46.5% of GlucoTrack shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.
GlucoTrack has lower revenue, but higher earnings than ReWalk Robotics. ReWalk Robotics is trading at a lower price-to-earnings ratio than GlucoTrack, indicating that it is currently the more affordable of the two stocks.
Summary
ReWalk Robotics beats GlucoTrack on 11 of the 16 factors compared between the two stocks.
Get GlucoTrack News Delivered to You Automatically
Sign up to receive the latest news and ratings for GCTK and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Media Sentiment Over Time
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
GlucoTrack Competitors List
Related Companies and Tools
This page (NASDAQ:GCTK) was last updated on 5/22/2025 by MarketBeat.com Staff
Buy GCTK Stock Free GCTK Stock Alerts